Paragon Private Wealth Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1922684
LEXINGTON, KY
Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$250,278
-$23,584 QoQ
Shares Held
1,981
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,786
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Paragon Private Wealth Management, LLC holds $10,562,173 across 8 Drug Manufacturers - General names. GILD ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,921 | $3,503,534 | |
| 2 | ABBV |
AbbVie Inc.
|
10,654 | $2,680,971 | |
| 3 | JNJ |
Johnson & Johnson
|
7,940 | $2,016,521 | |
| 4 | AMGN |
Amgen Inc
|
3,050 | $1,104,465 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,545 | $455,532 | |
| 6 | SNY |
Sanofi
|
8,000 | $341,280 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,981 | $250,278 | |
| 8 | PFE |
Pfizer Inc
|
8,704 | $209,592 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,278 | 1,981 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $273,862 | 1,965 | Shares | Defined | 2026-05-19 | |
| 2025-12-31 | $230,873 | 1,881 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||